Preclinical Rheumatic Disease, An Issue of Rheumatic Disease Clinics, 1st Edition
Author :
By Vivian P. Bykerk, BSc, MD, FRCPC
The ability to intervene at the earliest phases in the pathogenesis of a chronic rheumatic disease caused by auto-inflammatory, autoimmune, or tissue injury mechanisms has th epotential to prevent disease manifestations and consequences, limited loss
...view more
The ability to intervene at the earliest phases in the pathogenesis of a chronic rheumatic disease caused by auto-inflammatory, autoimmune, or tissue injury mechanisms has th epotential to prevent disease manifestations and consequences, limited loss of quality of life, comorbidity, and costs to society. This issue is dedicated to exploring the stages of rheumatic disease, biologic mechanisms contributing to the pathogenesis along with possible ways to study and screen for persons at risk with the ultimate goal of finding ways to prevent these devastating diseases.
The ability to intervene at the earliest phases in the pathogenesis of a chronic rheumatic disease caused by auto-inflammatory, autoimmune, or tissue injury mechanisms has th epotential to prevent disease manifestations and consequences, limited loss of quality of life, comorbidity, and costs to society. This issue is dedicated to exploring the stages of rheumatic disease, biologic mechanisms contributing to the pathogenesis along with possible ways to study and screen for persons at risk with the ultimate goal of finding ways to prevent these devastating diseases.
Author Information
By Vivian P. Bykerk, BSc, MD, FRCPC, Hospital for Special Surgery, New York, NY
https://www.asia.elsevierhealth.com/preclinical-rheumatic-disease-an-issue-of-rheumatic-disease-clinics-9780323320245.html294146Preclinical Rheumatic Disease, An Issue of Rheumatic Disease Clinicshttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780323320245_7.jpg89.0998.99USDInStock/Medicine & Surgery/Rheumatology/Clinics/Medicine/Rheumatology/Clinics/Clinics/Medicine/Rheumatology/Japan Titles43350904388725505455550546665255041525983552631601418269243350884886536505455351451205259833The ability to intervene at the earliest phases in the pathogenesis of a chronic rheumatic disease caused by auto-inflammatory, autoimmune, or tissue injury mechanisms has th epotential to prevent disease manifestations and consequences, limited loss of quality of life, comorbidity, and costs to society. This issue is dedicated to exploring the stages of rheumatic disease, biologic mechanisms contributing to the pathogenesis along with possible ways to study and screen for persons at risk with the ultimate goal of finding ways to prevent these devastating diseases. The ability to intervene at the earliest phases in the pathogenesis of a chronic rheumatic disease caused by auto-inflammatory, autoimmune, or tissue injury mechanisms has th epotential to prevent disease manifestations and consequences, limited loss of quality of life, comorbidity, and costs to society. This issue is dedicated to exploring the stages of rheumatic disease, biologic mechanisms contributing to the pathogenesis along with possible ways to study and screen for persons at risk with the ultimate goal of finding ways to prevent these devastating diseases.00add-to-cart97803233202452014ProfessionalBy Vivian P. Bykerk, BSc, MD, FRCPC20141Book152w x 229h (6.00" x 9.00")Elsevier0Oct 20, 2014IN STOCKBy <STRONG>Vivian P. Bykerk</STRONG>, BSc, MD, FRCPC, Hospital for Special Surgery, New York, NYClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
